Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Career Expectations and Preferences of Urology Residency Applicants.

Han J, Rabley A, Vlasak A, Bozorgmehri S, Bird V, Moy L.

Urology. 2018 Oct 10. pii: S0090-4295(18)31090-2. doi: 10.1016/j.urology.2018.07.070. [Epub ahead of print]

PMID:
30315888
2.

Abbreviated MRI of the Breast: Does It Provide Value?

Leithner D, Moy L, Morris EA, Marino MA, Helbich TH, Pinker K.

J Magn Reson Imaging. 2018 Sep 8. doi: 10.1002/jmri.26291. [Epub ahead of print]

PMID:
30194749
3.

Male Breast Cancer in the Age of Genetic Testing: An Opportunity for Early Detection, Tailored Therapy, and Surveillance.

Gao Y, Heller SL, Moy L.

Radiographics. 2018 Sep-Oct;38(5):1289-1311. doi: 10.1148/rg.2018180013. Epub 2018 Aug 3.

PMID:
30074858
4.

Respiratory care in familial dysautonomia: Systematic review and expert consensus recommendations.

Kazachkov M, Palma JA, Norcliffe-Kaufmann L, Bar-Aluma BE, Spalink CL, Barnes EP, Amoroso NE, Balou SM, Bess S, Chopra A, Condos R, Efrati O, Fitzgerald K, Fridman D, Goldenberg RM, Goldhaber A, Kaufman DA, Kothare SV, Levine J, Levy J, Lubinsky AS, Maayan C, Moy LC, Rivera PJ, Rodriguez AJ, Sokol G, Sloane MF, Tan T, Kaufmann H.

Respir Med. 2018 Aug;141:37-46. doi: 10.1016/j.rmed.2018.06.017. Epub 2018 Jun 21. Review.

5.

County-Level Factors Predicting Low Uptake of Screening Mammography.

Heller SL, Rosenkrantz AB, Gao Y, Moy L.

AJR Am J Roentgenol. 2018 Sep;211(3):624-629. doi: 10.2214/AJR.18.19541. Epub 2018 Jul 17.

PMID:
30016143
6.

Corrugated diaphragm shape design study for hemocompatible pulsatile ventricular assist devices.

Loosli C, Moy L, Kress G, Mazza E, Ermanni P.

Comput Methods Biomech Biomed Engin. 2018 Apr;21(5):399-407. doi: 10.1080/10255842.2018.1434623. Epub 2018 Jul 11.

PMID:
29996696
7.

Aerodigestive dysbiosis in children with chronic cough.

Kazachkov M, Kapoor BC, Malecha PW, Wu BG, Li Y, Levine J, Erkman J, Fitzgerald K, Moy L, Segal LN.

Pediatr Pulmonol. 2018 Sep;53(9):1288-1298. doi: 10.1002/ppul.24115. Epub 2018 Jul 8.

PMID:
29984544
8.

Assessing Transgender Patient Care and Gender Inclusivity of Breast Imaging Facilities Across the United States.

Goldberg JE, Moy L, Rosenkrantz AB.

J Am Coll Radiol. 2018 Aug;15(8):1164-1172. doi: 10.1016/j.jacr.2018.05.007. Epub 2018 Jun 20.

PMID:
29933975
9.

Incomplete Assumptions and Treatment Options Affect the Results of a Monte Carlo Simulation of Two Screening Mammography Strategies.

Moy L.

AJR Am J Roentgenol. 2018 Jul;211(1):W81. doi: 10.2214/AJR.18.19673. No abstract available.

PMID:
29932765
10.

Development of Anti-CD74 Antibody-Drug Conjugates to Target Glucocorticoids to Immune Cells.

Brandish PE, Palmieri A, Antonenko S, Beaumont M, Benso L, Cancilla M, Cheng M, Fayadat-Dilman L, Feng G, Figueroa I, Firdos J, Garbaccio R, Garvin-Queen L, Gately D, Geda P, Haines C, Hseih S, Hodges D, Kern J, Knudsen N, Kwasnjuk K, Liang L, Ma H, Manibusan A, Miller PL, Moy LY, Qu Y, Shah S, Shin JS, Stivers P, Sun Y, Tomazela D, Woo HC, Zaller D, Zhang S, Zhang Y, Zielstorff M.

Bioconjug Chem. 2018 Jul 18;29(7):2357-2369. doi: 10.1021/acs.bioconjchem.8b00312. Epub 2018 Jul 2.

PMID:
29923706
11.

Should We Continue to Biopsy All Amorphous Calcifications?

Moy L.

Radiology. 2018 Sep;288(3):680-681. doi: 10.1148/radiol.2018180767. Epub 2018 Jun 19. No abstract available.

PMID:
29916774
12.

Use of Breast Cancer Screening and Its Association with Later Use of Preventive Services among Medicare Beneficiaries.

Kang SK, Jiang M, Duszak R Jr, Heller SL, Hughes DR, Moy L.

Radiology. 2018 Sep;288(3):660-668. doi: 10.1148/radiol.2018172326. Epub 2018 Jun 5.

PMID:
29869958
13.

Hormonal Effects on Breast Density, Fibroglandular Tissue, and Background Parenchymal Enhancement.

Heller SL, Young Lin LL, Melsaether AN, Moy L, Gao Y.

Radiographics. 2018 Jul-Aug;38(4):983-996. doi: 10.1148/rg.2018180035. Epub 2018 Jun 1.

PMID:
29856684
14.

Treatment of burn scars in Fitzpatrick phototype III patients with a combination of pulsed dye laser and non-ablative fractional resurfacing 1550 nm erbium:glass/1927 nm thulium laser devices.

Tao J, Champlain A, Weddington C, Moy L, Tung R.

Scars Burn Heal. 2018 Feb 23;4:2059513118758510. doi: 10.1177/2059513118758510. eCollection 2018 Jan-Dec.

15.

A multiplexed microfluidic system for evaluation of dynamics of immune-tumor interactions.

Moore N, Doty D, Zielstorff M, Kariv I, Moy LY, Gimbel A, Chevillet JR, Lowry N, Santos J, Mott V, Kratchman L, Lau T, Addona G, Chen H, Borenstein JT.

Lab Chip. 2018 Jun 26;18(13):1844-1858. doi: 10.1039/c8lc00256h.

PMID:
29796561
16.

Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment.

Pinker K, Chin J, Melsaether AN, Morris EA, Moy L.

Radiology. 2018 Jun;287(3):732-747. doi: 10.1148/radiol.2018172171. Review.

PMID:
29782246
17.

Cosmetic Dermatology Training During Residency: Outcomes of a Resident-Reported Survey.

Champlain A, Reserva J, Webb K, Griffin D, Moy L, Joyce C, Glaser DA, Lawrence N, Lee KC, Antonovich DD, Duffy DM, Kim J, Ozog D, Sobanko J, Alam M, Tung RC.

Dermatol Surg. 2018 Sep;44(9):1216-1219. doi: 10.1097/DSS.0000000000001557.

PMID:
29781906
18.

Accuracy and precision of quantitative DCE-MRI parameters: How should one estimate contrast concentration?

Wake N, Chandarana H, Rusinek H, Fujimoto K, Moy L, Sodickson DK, Kim SG.

Magn Reson Imaging. 2018 Oct;52:16-23. doi: 10.1016/j.mri.2018.05.007. Epub 2018 May 16.

PMID:
29777820
19.

ACR Appropriateness Criteria® Breast Implant Evaluation.

Expert Panel on Breast Imaging:, Lourenco AP, Moy L, Baron P, Didwania AD, diFlorio RM, Heller SL, Holbrook AI, Lewin AA, Mehta TS, Niell BL, Slanetz PJ, Stuckey AR, Tuscano DS, Vincoff NS, Weinstein SP, Newell MS.

J Am Coll Radiol. 2018 May;15(5S):S13-S25. doi: 10.1016/j.jacr.2018.03.009.

PMID:
29724416
20.

Developments in Breast Imaging: Update on New and Evolving MR Imaging and Molecular Imaging Techniques.

Heller SL, Heacock L, Moy L.

Magn Reson Imaging Clin N Am. 2018 May;26(2):247-258. doi: 10.1016/j.mric.2017.12.003. Epub 2018 Feb 21. Review.

PMID:
29622129
21.

Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.

Pinker K, Moy L, Sutton EJ, Mann RM, Weber M, Thakur SB, Jochelson MS, Bago-Horvath Z, Morris EA, Baltzer PA, Helbich TH.

Invest Radiol. 2018 Oct;53(10):587-595. doi: 10.1097/RLI.0000000000000465.

PMID:
29620604
22.

Canceled MRI-guided Breast Biopsies Due to Nonvisualization: Follow-up and Outcomes.

Pinnamaneni N, Moy L, Gao Y, Melsaether AN, Babb JS, Toth HK, Heller SL.

Acad Radiol. 2018 Sep;25(9):1101-1110. doi: 10.1016/j.acra.2018.01.016. Epub 2018 Mar 1.

PMID:
29478921
23.

Stereotactic Breast Biopsy With Benign Results Does Not Negatively Affect Future Screening Adherence.

Lewin AA, Gao Y, Lin Young LL, Albert ML, Babb JS, Toth HK, Moy L, Heller SL.

J Am Coll Radiol. 2018 Apr;15(4):622-629. doi: 10.1016/j.jacr.2017.12.034. Epub 2018 Feb 9.

PMID:
29433804
24.

What Happens after a Diagnosis of High-Risk Breast Lesion at Stereotactic Vacuum-assisted Biopsy? An Observational Study of Postdiagnosis Management and Imaging Adherence.

Gao Y, Albert M, Young Lin LL, Lewin AA, Babb JS, Heller SL, Moy L.

Radiology. 2018 May;287(2):423-431. doi: 10.1148/radiol.2017171665. Epub 2018 Jan 29.

PMID:
29378151
25.

Associations of County-level Radiologist and Mammography Facility Supply with Screening Mammography Rates in the United States.

Rosenkrantz AB, Moy L, Fleming MM, Duszak R Jr.

Acad Radiol. 2018 Jul;25(7):883-888. doi: 10.1016/j.acra.2017.11.023. Epub 2018 Jan 17.

PMID:
29373212
26.

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.

Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA.

J Am Coll Radiol. 2018 Mar;15(3 Pt A):408-414. doi: 10.1016/j.jacr.2017.11.034. Epub 2018 Jan 19.

PMID:
29371086
27.

Do Tumor Shrinkage Patterns at Breast MR Imaging Predict Survival?

Moy L.

Radiology. 2018 Jan;286(1):58-59. doi: 10.1148/radiol.2017171975. No abstract available.

PMID:
29261475
28.

Screening Mammography Utilization and Medicare Beneficiaries' Perceptions of Their Primary Care Physicians.

Rosenkrantz AB, Fleming MM, Moy L, Babb JS, Duszak R Jr.

Acad Radiol. 2018 Apr;25(4):461-469. doi: 10.1016/j.acra.2017.10.023. Epub 2017 Dec 1.

PMID:
29199056
29.

Feasibility analysis of early temporal kinetics as a surrogate marker for breast tumor type, grade, and aggressiveness.

Heacock L, Lewin AA, Gao Y, Babb JS, Heller SL, Melsaether AN, Bagadiya N, Kim SG, Moy L.

J Magn Reson Imaging. 2018 Jun;47(6):1692-1700. doi: 10.1002/jmri.25897. Epub 2017 Nov 27.

PMID:
29178258
30.

The Discovery of 3-((4-Chloro-3-methoxyphenyl)amino)-1-((3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl)-1H-pyrazole-4-carboxamide, a Highly Ligand Efficient and Efficacious Janus Kinase 1 Selective Inhibitor with Favorable Pharmacokinetic Properties.

Siu T, Brubaker J, Fuller P, Torres L, Zeng H, Close J, Mampreian DM, Shi F, Liu D, Fradera X, Johnson K, Bays N, Kadic E, He F, Goldenblatt P, Shaffer L, Patel SB, Lesburg CA, Alpert C, Dorosh L, Deshmukh SV, Yu H, Klappenbach J, Elwood F, Dinsmore CJ, Fernandez R, Moy L, Young JR.

J Med Chem. 2017 Dec 14;60(23):9676-9690. doi: 10.1021/acs.jmedchem.7b01135. Epub 2017 Dec 4.

PMID:
29156136
31.

Screening for Breast Cancer in Women Age 75 Years and Older.

Lee CS, Moy L, Joe BN, Sickles EA, Niell BL.

AJR Am J Roentgenol. 2018 Feb;210(2):256-263. doi: 10.2214/AJR.17.18705. Epub 2017 Nov 7.

PMID:
29112471
32.

ACR Appropriateness Criteria® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer.

Expert Panel on Breast Imaging:, Slanetz PJ, Moy L, Baron P, diFlorio RM, Green ED, Heller SL, Holbrook AI, Lee SJ, Lewin AA, Lourenco AP, Niell B, Stuckey AR, Trikha S, Vincoff NS, Weinstein SP, Yepes MM, Newell MS.

J Am Coll Radiol. 2017 Nov;14(11S):S462-S475. doi: 10.1016/j.jacr.2017.08.037.

PMID:
29101985
33.

ACR Appropriateness Criteria® Breast Cancer Screening.

Expert Panel on Breast Imaging:, Mainiero MB, Moy L, Baron P, Didwania AD, diFlorio RM, Green ED, Heller SL, Holbrook AI, Lee SJ, Lewin AA, Lourenco AP, Nance KJ, Niell BL, Slanetz PJ, Stuckey AR, Vincoff NS, Weinstein SP, Yepes MM, Newell MS.

J Am Coll Radiol. 2017 Nov;14(11S):S383-S390. doi: 10.1016/j.jacr.2017.08.044.

PMID:
29101979
34.

Trends in breast imaging: an analysis of 21years of formal scientific abstracts at the Radiological Society of North America.

Heller SL, Charlie A, Babb JS, Moy L, Gao Y.

Clin Imaging. 2018 May - Jun;49:1-6. doi: 10.1016/j.clinimag.2017.10.018. Epub 2017 Oct 28.

PMID:
29100042
35.

Male Surgical Neck Rejuvenation.

Moy RL, Moy L.

Dermatol Surg. 2017 Nov;43 Suppl 2:S203-S207. doi: 10.1097/DSS.0000000000001347. Review. Retraction in: Dermatol Surg. 2018 Apr;44(4):605.

PMID:
29064986
36.

Harmonizing Breast Cancer Screening Recommendations: Metrics and Accountability.

Lee CS, Moy L, Friedewald SM, Sickles EA, Monticciolo DL.

AJR Am J Roentgenol. 2018 Feb;210(2):241-245. doi: 10.2214/AJR.17.18704. Epub 2017 Oct 18.

PMID:
29045178
37.

Improvement of Actinic Keratoses Using Topical DNA Repair Enzymes: A Randomized Placebo-Controlled Trial.

Stoddard M, Herrmann J, Moy L, Moy R.

J Drugs Dermatol. 2017 Oct 1;16(10):1030-1034.

PMID:
29036257
38.

Intravoxel incoherent motion (IVIM) histogram biomarkers for prediction of neoadjuvant treatment response in breast cancer patients.

Cho GY, Gennaro L, Sutton EJ, Zabor EC, Zhang Z, Giri D, Moy L, Sodickson DK, Morris EA, Sigmund EE, Thakur SB.

Eur J Radiol Open. 2017 Aug 18;4:101-107. doi: 10.1016/j.ejro.2017.07.002. eCollection 2017.

39.

Gender and Subspecialty of Urology Faculty in Department-based Leadership Roles.

Han J, Stillings S, Hamann H, Terry R, Moy L.

Urology. 2017 Dec;110:36-39. doi: 10.1016/j.urology.2017.07.044. Epub 2017 Aug 9.

PMID:
28802569
40.

Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging.

Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, Kopans DB, Eby PR, Sickles EA.

J Am Coll Radiol. 2017 Sep;14(9):1137-1143. doi: 10.1016/j.jacr.2017.06.001. Epub 2017 Jun 22.

PMID:
28648873
41.

Identification of quinazoline based inhibitors of IRAK4 for the treatment of inflammation.

Smith GF, Altman MD, Andresen B, Baker J, Brubaker JD, Chen H, Chen Y, Childers M, Donofrio A, Ferguson H, Fischer C, Fischmann TO, Gibeau C, Hicks A, Jin S, Kattar S, Kleinschek MA, Leccese E, Lesburg C, Li C, Lim J, Liu D, Maclean JKF, Mansoor F, Moy LY, Mulrooney EF, Necheva AS, Presland J, Rakhilina L, Yang R, Torres L, Zhang-Hoover J, Northrup A.

Bioorg Med Chem Lett. 2017 Jun 15;27(12):2721-2726. doi: 10.1016/j.bmcl.2017.04.050. Epub 2017 Apr 18.

PMID:
28501511
42.

ACR Appropriateness Criteria® Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women.

Expert Panel on Breast Imaging:, Moy L, Bailey L, D'Orsi C, Green ED, Holbrook AI, Lee SJ, Lourenco AP, Mainiero MB, Sepulveda KA, Slanetz PJ, Trikha S, Yepes MM, Newell MS.

J Am Coll Radiol. 2017 May;14(5S):S282-S292. doi: 10.1016/j.jacr.2017.02.009. Review.

PMID:
28473085
43.

ACR Appropriateness Criteria® Breast Pain.

Expert Panel on Breast Imaging:, Jokich PM, Bailey L, D'Orsi C, Green ED, Holbrook AI, Lee SJ, Lourenco AP, Mainiero MB, Moy L, Sepulveda KA, Slanetz PJ, Trikha S, Yepes MM, Newell MS.

J Am Coll Radiol. 2017 May;14(5S):S25-S33. doi: 10.1016/j.jacr.2017.01.028. Review.

PMID:
28473081
44.

ACR Appropriateness Criteria® Palpable Breast Masses.

Expert Panel on Breast Imaging:, Moy L, Heller SL, Bailey L, D'Orsi C, DiFlorio RM, Green ED, Holbrook AI, Lee SJ, Lourenco AP, Mainiero MB, Sepulveda KA, Slanetz PJ, Trikha S, Yepes MM, Newell MS.

J Am Coll Radiol. 2017 May;14(5S):S203-S224. doi: 10.1016/j.jacr.2017.02.033. Review.

PMID:
28473077
45.

ACR Appropriateness Criteria® Evaluation of Nipple Discharge.

Expert Panel on Breast Imaging:, Lee SJ, Trikha S, Moy L, Baron P, diFlorio RM, Green ED, Heller SL, Holbrook AI, Lewin AA, Lourenco AP, Niell BL, Slanetz PJ, Stuckey AR, Vincoff NS, Weinstein SP, Yepes MM, Newell MS.

J Am Coll Radiol. 2017 May;14(5S):S138-S153. doi: 10.1016/j.jacr.2017.01.030. Review.

PMID:
28473070
46.

Compressed Sensing for Breast MRI: Resolving the Trade-Off Between Spatial and Temporal Resolution.

Vreemann S, Rodriguez-Ruiz A, Nickel D, Heacock L, Appelman L, van Zelst J, Karssemeijer N, Weiland E, Maas M, Moy L, Kiefer B, Mann RM.

Invest Radiol. 2017 Oct;52(10):574-582. doi: 10.1097/RLI.0000000000000384.

PMID:
28463932
47.

Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.

Clarke CA, Canchola AJ, Moy LM, Neuhausen SL, Chung NT, Lacey JV Jr, Bernstein L.

Breast Cancer Res. 2017 May 1;19(1):52. doi: 10.1186/s13058-017-0840-7.

48.

Breast PET/MR Imaging.

Melsaether A, Moy L.

Radiol Clin North Am. 2017 May;55(3):579-589. doi: 10.1016/j.rcl.2016.12.011. Epub 2017 Feb 1. Review.

49.

Improvement of Atrophic Acne Scars in Skin of Color Using Topical Synthetic Epidermal Growth Factor (EGF) Serum: A Pilot Study.

Stoddard MA, Herrmann J, Moy L, Moy R.

J Drugs Dermatol. 2017 Apr 1;16(4):322-326.

PMID:
28403265
50.

Comprehensive Dynamic Contrast-Enhanced 3D Magnetic Resonance Imaging of the Breast With Fat/Water Separation and High Spatiotemporal Resolution Using Radial Sampling, Compressed Sensing, and Parallel Imaging.

Benkert T, Block KT, Heller S, Moccaldi M, Sodickson DK, Kim SG, Moy L.

Invest Radiol. 2017 Oct;52(10):583-589. doi: 10.1097/RLI.0000000000000375.

Supplemental Content

Support Center